Apoptotic mechanisms in fulminant hepatic failure: Potential therapeutic target

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 4, 2009, Pages 282-285

  Singhal, Shashideep ^a,e   Jain, Shilpa ^d   Kohaar, Indu ^c   Singla, Montish ^a   Gondal, Ranjana ^b   Kar, Premashis ^a,f  

^a LNJP Hospital   (India)

^b G B PANT HOSPITAL   (India)

^c Division of Molecular Genetics and Biochemistry   (India)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^f MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Apoptosis; Fas; Fulminant hepatic failure; TNF R1

Indexed keywords

DIISOPROPYLAMINE DICHLOROACETATE; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FAILURE; PATHOGENESIS; PRIORITY JOURNAL; VIRUS HEPATITIS;

ACUTE DISEASE; ANTIGENS, CD95; APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FAILURE, ACUTE; MALE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 68149165909     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181906f6d     Document Type: Article

References (20)

1. Sallie R, Silva AE, Purdy M, et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 1994;20:580-588. (Pubitemid 24149015)
2. Ostapowicz G, Fontana RJ, Schiodt FV, et al; US Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954.
3. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999;5:29-34. (Pubitemid 29037351)
4. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448-1455. (Pubitemid 26181228)
5. Dhiman RK, Seth AK, Jain S, et al. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998;43:1311-1316. (Pubitemid 28272568)
6. Kar P, Budhiraja S, Narang A, et al. Etiology of sporadic acute and fulminant non-A, non-B viral hepatitis in north India. Indian J Gastroenterol. 1997;16:43-45.
7. Acharya SK, Panda SK, Saxena A, et al. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol. 2000;15:473-479. (Pubitemid 30327047)
8. Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166-176.
9. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med. 2000;108: 567-574.
10. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature. 1993;364:806-809. (Pubitemid 23261761)
11. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 1995; 182:1223-1230.
12. Ryo K, Kamogawa Y, Yamauchi K, et al. Involvement of Fas and Fas ligand in case of human fulminant hepatitis. Nippon Rinsho. 1996;54:1965-1969.
13. Ryo K, Kamogawa Y, Ikeda I, et al. Significance of Fas antigenmediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol. 2000;95:2047-2055. (Pubitemid 30629305)
14. Rivero M, Crespo J, Fabrega E, et al. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral Hepat. 2002;9:107-113. (Pubitemid 36002473)
15. Mita A, Hashikura Y, Tagawa Y, et al. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure. Am J Gastroenterol. 2005;100:2551-2559. (Pubitemid 43919690)
16. Kasahara I, Saitoh K, Nakamura K. Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the TUNEL method and immunohistochemistry. J Med Dent Sci. 2000; 47:167-175.
17. De la Mata M, Meager A, Rolando N, et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol. 1990;82:479-484.
18. Streetz K, Leifeld L, Grundmann D, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology. 2000;119:446-460. (Pubitemid 30621995)
19. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282-298.
20. Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of Hepatitis B. Lancet. 1982;2:945-947. (Pubitemid 12030982)